Notable Labs Appoints Kaile Zagger as Interim CEO
Company Announcements

Notable Labs Appoints Kaile Zagger as Interim CEO

The latest update is out from Notable Labs ( (NTBL) ).

Notable Labs, Ltd. has announced Kaile A. Zagger as the new Interim CEO and Chief Restructuring Officer. With a strong background in healthcare and experience leading major corporate transformations, Zagger brings over 20 years of industry expertise to Notable. Her appointment follows her recent roles at Province, LLC and other notable healthcare firms. Dr. Joseph Wagner will remain Chief Scientific Officer after stepping down from his interim CEO position. Zagger’s expertise is expected to guide Notable through its next phase of development.

Find detailed analytics on NTBL stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskNotable Labs Files for Bankruptcy and Leadership Change
TheFlyVascular Biogenics Inc trading halted, news pending
TheFlyNotable Labs downgraded to Market Perform from Outperform at JMP Securities
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App